Medicine Information

Bextra Withdrawal Could Be Just the Beginning for Pfizer


The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Washington Post

Drugmakers may have to disclose prices of medicine in television ads
Washington Post
The nation's top health official proposed on Monday that pharmaceutical companies be required to include the list price of medicines in television advertisements to consumers — the boldest in a series of efforts by the Trump administration to curb ...
'Patients Deserve to Know': Trump Administration Wants Drug Commercials to Show PricesTIME
Trump Administration to Require Medicine Prices to Be Disclosed in TV AdsThe Epoch Times
US wants drug makers to disclose medicine prices in TV adsCBS News

all 191 news articles »


McCann Health's Global Scientific Council brings a valuable new resource for medicine, clients
Medical Marketing and Media
This Council is designed to help patients, healthcare practitioners and society as a whole better understand the complexities surrounding health and medicine. Together, McCann Health's 450-plus strong community of PhDs, MDs, pharmacists and other ...



WJHL-TV News Channel 11

ETSU Family Medicine presented HIMSS Davies Award of Excellence
WJHL-TV News Channel 11
JOHNSON CITY, Tenn. - A successful initiative by the Department of Family Medicine at East Tennessee State University to improve collaboration and communication after patients are discharged from the hospital was recognized by the Healthcare ...



UCLA Newsroom

UCLA neurosurgeon named to National Academy of Medicine
UCLA Newsroom
Dr. Linda Liau, an internationally renowned neurosurgeon-scientist and chair of the neurosurgery department at the David Geffen School of Medicine at UCLA, has been elected by her peers to the National Academy of Medicine, one of the highest honors in ...
Dell Medical School Professor Joins Prestigious National Academy of MedicineUT News | The University of Texas at Austin
Six Hopkins faculty members elected to National Academy of MedicineThe Hub at Johns Hopkins
Interoperability remains limited, according to the National Academy of MedicineHealthcare Finance News
UCSF News Services -Middletown Transcript -University of Michigan Health System News (press release)
all 32 news articles »


Harvard Medical School

6 HMS Faculty Elected to National Academy of Medicine
Harvard Medical School
Six HMS faculty members are among 75 researchers and clinicians elected as regular members of the National Academy of Medicine (NAM). One of the highest honors in the fields of health and medicine, membership in NAM recognizes individuals who have ...



USC News

Yang Chai elected to National Academy of Medicine
USC News
Ostrow Associate Dean of Research Yang Chai PhD '91, DDS '96 has been elected to the National Academy of Medicine (NAM), a membership which is considered one of the highest honors in the fields of health and medicine. “Your election reflects the high ...



Health Data Management

Penn Medicine lossens the reins to speed data to doctors
Health Data Management
Penn Medicine increasingly wants its clinicians to use information in its electronic health records system to understand what care their patients need. Called PennChart, the idea of its new initiative is to redesign the EHR to give clinicians automated ...
Penn Medicine's new transformation project looks to fill the 'middle space' between EHRs and cliniciansFierceHealthcare

all 2 news articles »


Michigan Medicine's Department of Physical Medicine & Rehabilitation partners with Mary Free Bed Rehabilitation ...
University of Michigan Health System News (press release)
“One of our strategic objectives is to build a statewide system for research in spinal cord injury that can lead to new innovation and discoveries,” says Denise Tate, Ph.D., professor of physical medicine and rehabilitation at Michigan Medicine and co ...



Bravo (blog)

Quad Webb-Lunceford Responds to the Married to Medicine Ladies' Shade with Even More Shade
Bravo (blog)
Do you feel that chill? That is the iciness that's formed between Quad Webb-Lunceford and her fellow Married to Medicine ladies this season. Many in the Married to Medicine crew are disappointed that Quad won't open up to them about what's really going ...



MobiHealthNews

Proteus, Otsuka expand their digital medicine collaboration with five-year, $88M deal
MobiHealthNews
Additionally, the five-year deal will also support the investigation of a wider digital medicine portfolio, Uneek Mehra, chief financial officer at Proteus Digital Health, told MobiHealthNews. “The $88 million investment — which includes equity and ...


Google News

home | site map | Dr. Thad Thomas
© 2006